These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 1935129)
1. Carcinogenic consequences of DNA alkylation. Michejda CJ Contrib Gynecol Obstet; 1991; 18():71-8. PubMed ID: 1935129 [No Abstract] [Full Text] [Related]
2. Correlations between sites of chemical modification of DNA, repair, and carcinogenesis. Singer B Princess Takamatsu Symp; 1982; 12():117-37. PubMed ID: 7166548 [No Abstract] [Full Text] [Related]
3. Use of alkylated proteins in the monitoring of exposure to alkylating agents. Farmer PB; Bailey E; Campbell JB IARC Sci Publ; 1984; (59):189-98. PubMed ID: 6545280 [TBL] [Abstract][Full Text] [Related]
4. Persistence of alkylated sites in DNA and its biological significance. Kleihues P; Schmerold I; Wiestler O Dev Toxicol Environ Sci; 1983; 11():255-64. PubMed ID: 6376057 [No Abstract] [Full Text] [Related]
5. Mice over-expressing human O6 alkylguanine-DNA alkyltransferase selectively reduce O6 methylguanine mediated carcinogenic mutations to threshold levels after N-methyl-N-nitrosourea. Allay E; Veigl M; Gerson SL Oncogene; 1999 Jun; 18(25):3783-7. PubMed ID: 10391687 [TBL] [Abstract][Full Text] [Related]
6. The biology of alkylating-agent cellular injury. Shulman LN Hematol Oncol Clin North Am; 1993 Apr; 7(2):325-35. PubMed ID: 8468267 [TBL] [Abstract][Full Text] [Related]
7. Significance of electrophilic reactivity and especially DNA alkylation in carcinogenesis and mutagenesis. Swenson DH Dev Toxicol Environ Sci; 1983; 11():247-54. PubMed ID: 6677460 [TBL] [Abstract][Full Text] [Related]
12. Glycine conjugated and free bile acids, aided by acid suppression, can easily enter the esophageal epithelium where they can activate oncogenes and eventually carcinogenesis. Stamp D Med Hypotheses; 2007; 68(6):1428-9. PubMed ID: 17134842 [No Abstract] [Full Text] [Related]
13. [New developments in the area of carcinogenic compounds and their pharmacodynamics (continuation and conclusion)]. Dannenberg H Dtsch Med J; 1967 Jun; 18(12):386-90 concl. PubMed ID: 5608293 [No Abstract] [Full Text] [Related]
14. A powerful selection assay for mixture libraries of DNA alkylating agents. Ham YW; Boger DL J Am Chem Soc; 2004 Aug; 126(30):9194-5. PubMed ID: 15281804 [TBL] [Abstract][Full Text] [Related]
15. O6-alkylguanine-DNA alkyltransferase: role in carcinogenesis and chemotherapy. Margison GP; Santibáñez-Koref MF Bioessays; 2002 Mar; 24(3):255-66. PubMed ID: 11891762 [TBL] [Abstract][Full Text] [Related]
16. Mammalian O6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents. Pegg AE Cancer Res; 1990 Oct; 50(19):6119-29. PubMed ID: 2205376 [No Abstract] [Full Text] [Related]
17. The biological effects of N3-methyladenine. Fronza G; Gold B J Cell Biochem; 2004 Feb; 91(2):250-7. PubMed ID: 14743385 [TBL] [Abstract][Full Text] [Related]
18. Estimation of the potencies of chemicals that produce genetic damage. Peterson AR; Peterson H Carcinog Compr Surv; 1985; 10():495-509. PubMed ID: 3904996 [No Abstract] [Full Text] [Related]
19. Transforming collaborations between ras and nuclear oncogenes. Ruley HE Cancer Cells; 1990; 2(8-9):258-68. PubMed ID: 2223387 [TBL] [Abstract][Full Text] [Related]
20. [Genes of DNA stabilization and carcinogenesis]. Kiselev FL Mol Biol (Mosk); 1998; 32(2):197-205. PubMed ID: 9608934 [No Abstract] [Full Text] [Related] [Next] [New Search]